Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.02
Data as of 4:00pm ET
 -0.03 / -1.46%
Today’s Change
1.71
Today|||52-Week Range
5.30
+9.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues1.1M7.4M2.7M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income-430.0K3.3M1.1M1.9M
 
 
 
 
 
Total Operating Expenses13.7M15.9M10.2M11.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.6M-8.6M-7.6M-8.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-7.3M-6.1M-8.0M
 
 
 
 
 
Net Income-10.9M-7.3M-6.1M-8.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS90.7M92.7M92.8M93.0M
 
 
 
 
 
Shares To Calculate EPS Diluted90.7M92.7M92.8M93.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.08-$0.07-$0.09
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.